HLA-G and Recurrent Pregnancy Loss

Area of Science:

• Reproductive immunology
• Maternal-fetal immune tolerance

Background:

• Placentation involves complex maternal immune and trophoblastic cell interactions.
• Human Leukocyte Antigen G (HLA-G) on trophoblasts modulates maternal immune responses.
• Recurrent pregnancy loss (RPL) affects 5% of pregnancies, with many cases unexplained.

Purpose of the Study:

• To review the role of HLA-G pathway alterations in recurrent pregnancy loss.
• To explore the immunological mechanisms underlying pregnancy loss.
• To understand the disruption of maternal-fetal immune balance.

Main Methods:

• Literature review focusing on HLA-G and recurrent pregnancy loss.
• Analysis of immunological interactions between maternal and trophoblastic cells.
• Comparison of miscarriage and allograft rejection immunology.

Main Results:

• HLA-G is a critical molecule in establishing maternal-fetal immune equilibrium.
• Aberrations in the HLA-G pathway disrupt immune tolerance.
• Impaired HLA-G function is associated with an increased risk of RPL.

Conclusions:

• The HLA-G pathway is crucial for successful pregnancy maintenance.
• Dysregulation of HLA-G contributes significantly to unexplained recurrent pregnancy loss.
• Targeting HLA-G pathways may offer therapeutic strategies for RPL.